| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 672140 | 71101 | LATANOPROST TEVA-RATIOPHARM 50 microgramos/ml COLIRIO EN SOLUCION | LATANOPROST TEVA-RATIOPHARM 50 microgramos/ml COLIRIO EN SOLUCION, 1 frasco de 2,5 ml | 50 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71101/71101_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71101/71101_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2010-02-09 | 1 | 1 | 1 | 2010-02-09 | 2011-03-09 | 1 | 2011-07-23 | 664794 | View Edit Delete | |||||||||||
| 682687 | 11694002 | NULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | NULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 2 viales | 250 microgramos | 45 | 2 | 34 | 2 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11694002/11694002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11694002/11694002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | 37363 | 2011-08-02 | 1 | 1 | 1 | 2011-08-02 | 2011-08-02 | 1 | 2013-08-01 | View Edit Delete | ||||||||||||
| 698447 | 107396002 | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 3 viales + 3 viales de disolvente | 150 UI/75 UI | 45 | 3 | 34 | 3 viales + 3 viales de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/107396002/107396002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/107396002/107396002_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29251 | 88146 | 2013-07-01 | 1 | 1 | 1 | 2013-07-01 | 2013-07-01 | 1 | 2014-02-20 | View Edit Delete | ||||||||||||
| 723374 | 83358 | PROLASPLAN 1000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | PROLASPLAN 1000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION , 1 vial de polvo + 1 vial de disolvente | 1000 mg | 83 | 1 | 34 | 1 vial de polvo + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83358/83358_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83358/83358_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2018-08-02 | 1 | 1 | 1 | 2018-08-03 | 2018-08-03 | 1 | 2019-01-25 | View Edit Delete | ||||||||||||
| 724967 | 1181331001 | LUXTURNA 5 x 10¹² GENOMAS VECTORIALES/ML CONCENTRADO Y DISOLVENTE PARA SOLUCION INYECTABLE | LUXTURNA 5 x 10¹² GENOMAS VECTORIALES/ML CONCENTRADO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 0,5 ml (concentrado) + 2 viales de 1,7 ml (disolvente) | 5 x 10e12 genomas vectoriales inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml (concentrado) + 2 viales de 1,7 ml (disolvente) | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1181331001/1181331001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181331001/1181331001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | 1945 | 2019-04-02 | 1 | 1 | 1 | 2019-04-03 | 2019-04-02 | 1 | 2021-03-23 | View Edit Delete | ||||||||||||
| 726150 | 84262 | PRAMEP 20 MG/ML SOLUCION ORAL EFG | PRAMEP 20 MG/ML SOLUCION ORAL EFG, 1 frasco de 473 ml | 20 mg/ml | 6 | 473 | 26 | 1 frasco de 473 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84262/84262_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84262/84262_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2019-06-14 | 1 | 1 | 1 | 2019-06-15 | 2019-06-14 | 1 | 2019-09-05 | View Edit Delete | ||||||||||||
| 727060 | 84548 | ETACORTILEN 1,5 MG/ML COLIRIO EN SOLUCION | ETACORTILEN 1,5 MG/ML COLIRIO EN SOLUCION, 20 envases unidosis de 0,3 ml | 1,5 mg/ml | 37 | 20 | 16 | 20 envases unidosis de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84548/84548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84548/84548_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3452 | 41329 | 2019-10-15 | 1 | 1 | 1 | 2019-10-16 | 2019-10-15 | 1 | 2023-08-29 | View Edit Delete | ||||||||||||
| 727261 | 1151006002 | RESPREEZA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | RESPREEZA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial) | 4.000 mg | 83 | 1 | 34 | 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151006002/1151006002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151006002/1151006002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2019-11-06 | 1 | 1 | 1 | 2019-11-07 | 2019-11-06 | 1 | 2020-02-07 | View Edit Delete | ||||||||||||
| 727262 | 1151006003 | RESPREEZA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | RESPREEZA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial) | 5000 mg | 83 | 1 | 34 | 1 vial + 1 vial + 1 trasvasador 20/20 (Mix2Vial) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151006003/1151006003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151006003/1151006003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | 37033 | 2019-11-06 | 1 | 1 | 1 | 2019-11-07 | 2019-11-06 | 1 | 2020-02-07 | View Edit Delete | ||||||||||||
| 728933 | 85248 | DUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCION | DUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCION, 1 frasco de 5 ml | 1 mg/ml + 5 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85248/85248_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85248/85248_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2543 | 23784 | 2020-07-13 | 1 | 1 | 1 | 2020-07-14 | 2020-07-13 | 1 | 2021-01-04 | View Edit Delete | ||||||||||||
| 729935 | 85629 | NETDEX 3 MG/ML + 1 MG/ML GEL OFTALMICO EN ENVASE UNIDOSIS | NETDEX 3 MG/ML + 1 MG/ML GEL OFTALMICO EN ENVASE UNIDOSIS, 15 envases unidosis de 0,4 ml | 1 mg/ml + 3 mg/ml | 37 | 15 | 16 | 15 envases unidosis de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85629/85629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85629/85629_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3452 | 41329 | 2020-12-09 | 1 | 1 | 1 | 2020-12-10 | 2020-12-09 | 1 | 2023-11-22 | View Edit Delete | ||||||||||||
| 731120 | 1191371002 | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 3 ml | 100 mg/ml inyectable 3 ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371002/1191371002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371002/1191371002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | 71490 | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 731121 | 1191371003 | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION | ULTOMIRIS 1100 mg/11 ml CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 11 ml | 100 mg/ml inyectable 11 ml | 45 | 1 | 34 | 1 vial de 11 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191371003/1191371003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191371003/1191371003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31986 | 71490 | 2021-06-11 | 1 | 1 | 1 | 2021-06-12 | 2021-06-11 | 1 | 2022-05-13 | View Edit Delete | ||||||||||||
| 731388 | 86106 | PREMAX 20 MG/ML SOLUCION ORAL EFG | PREMAX 20 MG/ML SOLUCION ORAL EFG, 1 frasco de 473 ml | 20 mg/ml | 6 | 473 | 26 | 1 frasco de 473 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86106/86106_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86106/86106_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | 30261 | 2021-07-26 | 1 | 1 | 1 | 2021-07-27 | 2021-07-26 | 1 | 2022-01-13 | View Edit Delete | ||||||||||||
| 758015 | 1221659001 | XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | XENPOZYME 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 20 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221659001/1221659001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221659001/1221659001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42448 | 40842 | 2022-07-29 | 1 | 1 | 1 | 2022-07-30 | 2022-07-29 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 758019 | 1171216010 | IMRALDI 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | IMRALDI 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa de 0,4 ml | 40 mg inyectable 0,4 ml | 33 | 1 | 61 | 1 jeringa de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171216010/1171216010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171216010/1171216010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 19066 | 2022-07-21 | 1 | 1 | 1 | 2022-07-22 | 2022-07-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 758020 | 1171216010 | IMRALDI 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | IMRALDI 40 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas de 0,4 ml | 40 mg inyectable 0,4 ml | 33 | 2 | 61 | 2 jeringas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171216010/1171216010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171216010/1171216010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 19066 | 2022-07-21 | 1 | 1 | 1 | 2022-07-22 | 2022-07-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 758021 | 1171216014 | IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 1 pluma de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 1 | 49 | 1 pluma de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171216014/1171216014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171216014/1171216014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 19066 | 2022-07-21 | 1 | 1 | 1 | 2022-07-22 | 2022-07-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 758022 | 1171216014 | IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA | IMRALDI 40 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA, 2 plumas de 0,4 ml | 40 mg inyectable 0,4 ml | 66 | 2 | 49 | 2 plumas de 0,4 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171216014/1171216014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171216014/1171216014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29985 | 19066 | 2022-07-21 | 1 | 1 | 1 | 2022-07-22 | 2022-07-21 | 1 | 2023-03-13 | View Edit Delete | ||||||||||||
| 758197 | 1221674001 | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN | VYVGART 20 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial de 20 ml | 20 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221674001/1221674001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221674001/1221674001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 41147 | 71016 | 2022-09-29 | 1 | 1 | 1 | 2022-09-30 | 2022-09-29 | 1 | 2023-11-13 | View Edit Delete | ||||||||||||
| 762543 | 1221659005 | XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | XENPOZYME 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 4 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1221659005/1221659005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1221659005/1221659005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 42448 | 40842 | 2023-05-04 | 1 | 1 | 1 | 2023-05-05 | 2023-05-04 | 1 | 2024-05-14 | View Edit Delete | ||||||||||||
| 762949 | 1231735001 | EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | EPYSQLI 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 30 ml | 300 mg inyectable 30 ml | 45 | 1 | 59 | 1 vial de 30 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231735001/1231735001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231735001/1231735001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29985 | 29985 | 2023-06-20 | 1 | 1 | 1 | 2023-06-21 | 2023-06-20 | 1 | 2023-08-10 | View Edit Delete | ||||||||||||
| 763556 | 89084 | PROLASTINA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN | PROLASTINA 4.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial polvo + 1 vial disolvente de 160 ml + 1 dispositivo de transferencia | 4.000 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente de 160 ml + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89084/89084_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89084/89084_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | 3896 | 2024-02-19 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-09-06 | View Edit Delete | ||||||||||||
| 763559 | 89085 | PROLASTINA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN | PROLASTINA 5.000 MG POLVO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN, 1 vial polvo + 1 vial disolvente de 200 ml + 1 dispositivo de transferencia | 5.000 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente de 200 ml + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89085/89085_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89085/89085_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | 3896 | 2024-02-19 | 1 | 1 | 1 | 2024-02-19 | 2024-02-19 | 1 | 2024-09-06 | View Edit Delete | ||||||||||||
| 763945 | 1231764001 | ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA | ZILBRYSQ 16,6 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 7 jeringas precargadas | 16,6 mg inyectable 0,416 ml | 33 | 7 | 61 | 7 jeringas precargadas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231764001/1231764001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231764001/1231764001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2023-12-22 | 1 | 1 | 1 | 2023-12-23 | 2023-12-22 | 1 | 2024-07-31 | View Edit Delete | ||||||||||||
| 763947 | 1231764003 | ZILBRYSQ 23 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA | ZILBRYSQ 23 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 7 jeringas precargadas | 23 mg inyectable 0,574 ml | 33 | 7 | 61 | 7 jeringas precargadas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231764003/1231764003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231764003/1231764003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2023-12-22 | 1 | 1 | 1 | 2023-12-23 | 2023-12-22 | 1 | 2024-07-31 | View Edit Delete | ||||||||||||
| 763948 | 1231764005 | ZILBRYSQ 32,4 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA | ZILBRYSQ 32,4 MG, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 7 jeringas precargadas | 32,4 mg inyectable 0,81 ml | 33 | 7 | 61 | 7 jeringas precargadas | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1231764005/1231764005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1231764005/1231764005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8910 | 21333 | 2023-12-22 | 1 | 1 | 1 | 2023-12-23 | 2023-12-22 | 1 | 2024-07-31 | View Edit Delete | ||||||||||||
| 766185 | 1241840002 | AKANTIOR 0,8 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | AKANTIOR 0,8 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS, 30 envases unidosis de 0,3 ml | 0,8 mg/ml | 37 | 30 | 16 | 30 envases unidosis de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1241840002/1241840002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241840002/1241840002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 3452 | 41329 | 2024-11-12 | 1 | 1 | 1 | 2024-11-13 | 2024-11-12 | 1 | 2025-07-15 | View Edit Delete | ||||||||||||
| 769322 | 90820 | PROLASPLAN 4.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION | PROLASPLAN 4.000 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION, 1 vial polvo + 1 vial disolvente 160 ml + 1 dispositivo de transferencia | 4.000 mg | 45 | 1 | 34 | 1 vial polvo + 1 vial disolvente 160 ml + 1 dispositivo de transferencia | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90820/90820_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90820/90820_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3896 | 3896 | 2025-12-01 | 1 | 1 | 1 | 2025-12-02 | 2025-12-01 | 1 | 2026-04-13 | View Edit Delete |